Cyclic nucleotide phosphodiesterase and aggregation in platelets from diabetic rats

Area of Science:

• Biochemistry
• Endocrinology
• Pharmacology

Background:

• Platelet aggregation and cyclic nucleotide phosphodiesterase (PDE) are crucial in hemostasis and cellular signaling.
• Diabetes mellitus is associated with cardiovascular complications, potentially involving platelet dysfunction and altered PDE activity.

Purpose of the Study:

• To investigate platelet aggregation and cyclic nucleotide phosphodiesterase (PDE) activity in a novel insulin-dependent spontaneously diabetic rat (SDR) model.
• To compare these findings with streptozotocin-induced diabetic rats (STZ).
• To assess the effect of insulin on these parameters in SDR.

Main Methods:

• Washed platelet aggregation assays using ADP and ionophore A23187.
• Measurement of soluble and particulate cAMP-PDE and cGMP-PDE activities in platelets, liver, and heart.
• Kinetic analysis of soluble cGMP-PDE.
• Administration of insulin to SDR.

Main Results:

• SDR showed decreased platelet aggregation and increased soluble cGMP-PDE activity, with altered kinetics (lower Km, higher Vmax).
• SDR exhibited increased particulate cAMP-PDE and cGMP-PDE activities in liver and heart.
• Insulin partially corrected these anomalies in SDR.
• STZ-induced diabetic rats displayed increased platelet aggregation and decreased soluble cGMP-PDE activity, with decreased liver cAMP-PDE activity.

Conclusions:

• Diabetes induces distinct alterations in platelet function and PDE activity depending on the model.
• The findings in SDR contrast with STZ-induced diabetes, highlighting the complexity of PDE involvement in diabetes pathophysiology.
• Further research is needed to elucidate the precise role of these anomalies in diabetes.